Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Tekmira Pharmaceuticals Corp T.TKM

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  TKMR

Tekmira Pharmaceuticals Corp develops ribonucleic acid interference therapeutic product candidates as well as provides its lipid nanoparticle delivery technology to pharmaceutical partners in the Canada.

Latest Tekmira Pharmaceuticals Corp News

1 2 3 4 5 6 7 Next

Tekmira Initiates Phase I Clinical Trial of TKM-HBV

GlobeNewswire   January 21, 2015

Tekmira Pharmaceuticals Announces Leadership Changes

GlobeNewswire   December 19, 2014

Tekmira Files Shelf Registration Statement

GlobeNewswire   November 26, 2014

Tekmira to Present at Stifel Healthcare Conference

GlobeNewswire   November 12, 2014

Ebola Watch: Tekmira (T.TKM) gears up to release Q3 financials

Stockhouse Editorial   November 5, 2014

Ebola Stocks are the New and Improved VIX

Accesswire   October 28, 2014
1 2 3 4 5 6 7 Next